Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Amber M Aeilts"'
Autor:
Amber M. Aeilts, Kristen M. Carpenter, Shelly R. Hovick, Lindsey Byrne, Abigail B. Shoben, Leigha Senter
Publikováno v:
Journal of genetic counselingREFERENCES.
While genetic testing for hereditary breast and ovarian cancer syndrome (HBOC) is well-established in the field of medicine, family members' uptake of cascade genetic testing for known familial pathogenic variants remains low. Probands often become r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cc0f5db9d3274ab93a0fe37a0a9e5de
https://pubmed.ncbi.nlm.nih.gov/36426678
https://pubmed.ncbi.nlm.nih.gov/36426678
Autor:
Leigha Senter, Lindsey Byrne, Shelly R. Hovick, Abigail B. Shoben, Kristen M. Carpenter, Amber M Aeilts
Publikováno v:
Journal of genetic counselingREFERENCES. 30(3)
Cascade genetic testing is essential to clarify cancer risk in families with hereditary breast and ovarian cancer syndrome (HBOC) due to pathogenic variants (PVs) in BRCA1 or BRCA2. To date, data suggest that family communication of genetic testing r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55ec89e02a32ebe5acb71b2633cf1942
https://pubmed.ncbi.nlm.nih.gov/33142025
https://pubmed.ncbi.nlm.nih.gov/33142025
Autor:
Joanne M. Jeter, Kiranveer Kaur, Maryam B. Lustberg, Dori Klemanski, Menglin Xu, Namrata Vilas Shinde, Amber M Aeilts
Publikováno v:
Journal of Clinical Oncology. 39:e24110-e24110
e24110 Background: Genetic testing results for germline mutations impact care of cancer survivors, thus are important to include in a survivorship care plan (SCP). In 2014, the Commission on Cancer adopted the American Society of Clinical Oncology’
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ade7ec00174ff0ed9f0775471bb020b1
https://doi.org/10.1200/jco.2021.39.15_suppl.e24110
https://doi.org/10.1200/jco.2021.39.15_suppl.e24110